Advertisement
Advertisement
Bexsero

Bexsero Indications/Uses

vaccine, meningococcal

Manufacturer:

GlaxoSmithKline Vaccines

Distributor:

GlaxoSmithKline
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Meningococcal Group B Vaccine (Bexsero) is indicated for active immunisation of individuals from 2 months of age and older against invasive meningococcal disease caused by Neisseria meningitidis group B (see Pharmacology: Pharmacodynamics: Pharmacodynamic effects under Actions for information on protection against specific group B strains).
The use of Meningococcal Group B Vaccine (Bexsero) should be in accordance with official recommendations.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement